Trellus Health Statistics
Total Valuation
Trellus Health has a market cap or net worth of GBP 1.53 million. The enterprise value is -1.94 million.
Market Cap | 1.53M |
Enterprise Value | -1.94M |
Important Dates
The next estimated earnings date is Thursday, June 26, 2025.
Earnings Date | Jun 26, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Trellus Health has 161.51 million shares outstanding.
Current Share Class | 161.51M |
Shares Outstanding | 161.51M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 18.18% |
Owned by Institutions (%) | 72.83% |
Float | 85.30M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 16.85 |
PB Ratio | 0.16 |
P/TBV Ratio | 0.46 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 0.31 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.15
Current Ratio | 12.15 |
Quick Ratio | 12.15 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -49.78% and return on invested capital (ROIC) is -32.09%.
Return on Equity (ROE) | -49.78% |
Return on Assets (ROA) | -30.94% |
Return on Invested Capital (ROIC) | -32.09% |
Return on Capital Employed (ROCE) | -68.22% |
Revenue Per Employee | 4,793 |
Profits Per Employee | -327,159 |
Employee Count | 19 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.03% in the last 52 weeks. The beta is 2.25, so Trellus Health's price volatility has been higher than the market average.
Beta (5Y) | 2.25 |
52-Week Price Change | -31.03% |
50-Day Moving Average | 1.76 |
200-Day Moving Average | 1.41 |
Relative Strength Index (RSI) | 8.05 |
Average Volume (20 Days) | 586,581 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Trellus Health had revenue of GBP 91,060 and -6.22 million in losses. Loss per share was -0.04.
Revenue | 91,060 |
Gross Profit | 91,060 |
Operating Income | -6.41M |
Pretax Income | -6.22M |
Net Income | -6.22M |
EBITDA | -5.72M |
EBIT | -6.41M |
Loss Per Share | -0.04 |
Balance Sheet
The company has 3.47 million in cash and n/a in debt, giving a net cash position of 3.47 million or 0.02 per share.
Cash & Cash Equivalents | 3.47M |
Total Debt | n/a |
Net Cash | 3.47M |
Net Cash Per Share | 0.02 |
Equity (Book Value) | 9.40M |
Book Value Per Share | 0.06 |
Working Capital | 3.31M |
Cash Flow
Operating Cash Flow | -5.85M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 100.00% |
Operating Margin | -7,041.21% |
Pretax Margin | -6,826.30% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Trellus Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -405.13% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |